The study included all 50- to 69-year-old women diagnosed with invasive and in-situ BC (ICD-10: C50 and D05) between 2010 and 2019 in the Swiss cantons of St. Gallen and Grisons. BC was either diagnosed within or outside the “donna” MSP. Cancer data was retrieved from the databas...
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016;164(4):279-296. doi:10.7326/M15-2886 PubMedGoogle Scholar 30. Wilkinson E. COVID-19 pandemic to lead to thousands of additional UK lung cancer deaths. Lancet ...
Assessment of women with atypical squamous cells of undetermined significance (ASCUS). This is consistent with the National Cancer Institute's interim guidelines for managing abnormal cervical cytology as well as the position of the American Society for Colposcopy and Cervical Pathology (ASCCP) for the...
We questioned whether a history of negative screening outcomes could be used to predict breast cancer risk, and thus be used as a potential factor for stra
BREAST cancerMAMMOGRAMSCANCER patientsOVERALL survivalCANCER relapseStudy goal: We compared the survival rates of women with breast cancer (BC) detected within versus outside the mammography screening program (MSP) "donna". Methods: We merged data from the MSP with the data from corresponding cancer...
To increase the statistical power of the analyses, we followed the stratification of cancers provided by UKBB53. Patient groups were identified based on specific ICD-10 codes, including breast cancer (C50), bladder cancer (C76), colorectal cancer (C18, C20), kidney cancer (C64), leukemia (...
In the data analysis, the two types of screening were distinguished by the codes from health care claim, and we present coverage estimates separately for general population, and WLWH. An organised CC screening episode is defined on the bases of a health claim with the ICD-10 diagnosis code ...
Whereas other investigators10-16,25 have observed an association between preventive visits and cancer testing, the present study provides timely confirmation and quantification of the association between PHEs and completion of CRC, breast cancer, and prostate cancer testing in population-based cohorts ...
Therefore, most of the time, unaffected relatives of patients gave the informed consent in the study. All diagnoses were coded according to the ICD-10 criteria. Usually there was no attempt to use results of the clock test in the diagnostic workup. Patients received standard outpatient medical ...
cancer screening participation rates, with odds of screening as low as 0.5 compared to reference populations [8,9,10]. However, there are gaps and inconsistencies in the evidence regarding breast cancer screening. Many studies have examined small clinical cohorts. Some population studies use self-...